Sydney M Crago is a journalist at Ophthalmology Times. She focuses on themes related to medicine and healthcare, including medical specialties, alternative medicine, and diagnostics. Sydney's work has been featured in Ophthalmology Times and Optometry Times.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Not enough data
Sydney M Crago’s articles predominantly cover medical research, with a focus on eye health and pharmaceutical industry developments. The coverage includes presentations of scientific data, expert commentary, and announcements related to these topics.
If you are looking to pitch to Sydney M Crago, consider offering expert commentary or insights into recent medical research developments in the field of ophthalmology and pharmaceuticals. Additionally, if you have access to new scientific data or can provide analysis based on such information, it may be particularly appealing for her audience.
Given the specific nature of the topics covered by Sydney M Crago, content related to deep learning in medical research or updates from prestigious associations like ASRS (American Society of Retina Specialists) could also be well-received.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Sydney M Crago
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.
By: Sydney M Crago
At Retina World Congress 2025, Dilsher S. Dhoot, MD, shares updates on the HELIOS trial and the potential future of tyrosine kinase inhibitors (TKIs)
By: Siegfried Priglinger, Sydney M Crago
At the Retina World Congress, we spoke with Siegfried Priglinger, MD, about ensuring the best outcomes for preschool-aged patients
The ARCHER trial assessed ANX007 for GA in dry AMD, showing reduced vision loss despite not meeting the primary endpoint.
Uveitis treatment advancements aim to reduce steroid reliance, exploring systemic, local, and topical therapies to control disease activity without side effects.
By: Rachel Downes, Sydney M Crago
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.
By: J. Fernando Arevalo, Sydney M Crago
The ELEVATUM study explored faricimab's effectiveness in treating diabetic macular edema among underrepresented minorities, showcasing significant visual acuity improvements.
By: Sydney M Crago, Jay Chhablani
Jay Chhablani, MD, explains how 3D choroidal vessel segmentation transforms ophthalmology, enhancing disease diagnosis and treatment through advanced imaging technology.
By: Sydney M Crago
Ocular Therapeutix showcases innovative retinal disease treatments at the Clinical Trials Summit 2025 in Las Vegas, featuring presentations and discussions.
By: Sydney M Crago
Assistive devices empower patients with central vision loss to regain independence, enhancing daily activities and reducing reliance on low vision centers.
(833) 317-6278 
